Cell-free DNA-A marker to predict ischemic brain damage in a rat stroke experimental model

Journal of Neurosurgical Anesthesiology

Volumn 23, Issue 3, 2011, Pages 222-228

  Boyko, Matthew ^a   Ohayon, Sharon ^a   Goldsmith, Tomer ^a   Douvdevani, Amos ^a   Gruenbaum, Benjamin Fredrick ^a   Melamed, Israel ^a   Knyazer, Boris ^a   Shapira, Yoram ^a   Teichberg, Vivian I ^b   Elir, Adina ^a   Klein, Moti ^a   Zlotnik, Alexander ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

biomarker; brain injury; cell free DNA; ischemic insult; middle cerebral artery occlusion; neurologic performance; stroke

Indexed keywords

CELL FREE DNA; DNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL FREE SYSTEM; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE; TASK PERFORMANCE;

ANIMALS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CELL-FREE SYSTEM; DISEASE MODELS, ANIMAL; DNA; MALE; PREDICTIVE VALUE OF TESTS; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

EID: 79959189694     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0b013e31821b536a     Document Type: Article

References (44)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation. 2010;121:e46-e215.
2. Guo JM, Liu AJ, Su DF. Genetics of stroke. Acta Pharmacol Sin. 2010;31:1055-1064.
3. Traystman RJ. Animal models of focal and global cerebral ischemia. ILAR J. 2003;44:85-95. (Pubitemid 36410962)
4. Cheng YD, Al-Khoury L, Zivin JA. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx. 2004;1:36-45. (Pubitemid 46589340)
5. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20:84-91. (Pubitemid 19040218)
6. Belayev L, Alonso OF, Busto R, et al. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke. 1996;27: 1616-1122; discussion 1623.
7. Yu F, Sugawara T, Chan PH. Treatment with dihydroethidium reduces infarct size after transient focal cerebral ischemia in mice. Brain Res. 2003;978:223-227. (Pubitemid 36776642)
8. Spratt NJ, Fernandez J, Chen M, et al. Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J Neurosci Methods. 2006;155:285-290. (Pubitemid 44233014)
9. Di Napoli M, Schwaninger M, Cappelli R, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke. 2005;36:1316-1329. (Pubitemid 40798763)
10. Rallidis LS, Vikelis M, Panagiotakos DB, et al. Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients. Acta Neurol Scand. 2008;117:415-420. (Pubitemid 351643673)
11. Perez M, Wandosell F, Colaco C, et al. Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment. Biochem J. 1998;335:369-374. (Pubitemid 28491072)
12. Shenhar-Tsarfaty S, Ben Assayag E, Bova I, et al. Interleukin-6 as an early predictor for one-year survival following an ischaemic stroke/transient ischaemic attack. Int J Stroke. 2010;5:16-20.
13. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids-a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007;581:795-799. (Pubitemid 46282711)
14. Shimony A, Zahger D, Gilutz H, et al. Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients. Acute Card Care. 2010;12:109-111.
15. Lam NY, Rainer TH, Wong LK, et al. Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 hours of symptom onset. Resuscitation. 2006;68:71-78. (Pubitemid 43053370)
16. Rainer TH, Wong LK, Lam W, et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem. 2003;49:562-569. (Pubitemid 36379520)
17. Goldshtein H, Hausmann MJ, Douvdevani A. A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids. Ann Clin Biochem. 2009;46:488-494.
18. Boyko M, Zlotnik A, Gruenbaum BF, et al. An experimental model of focal ischemia using an internal carotid artery approach. J Neurosci Methods. 2010;193:246-253.
19. Dittmar M, Spruss T, Schuierer G, et al. External carotid artery territory ischemia impairs outcome in the endovascular filament model of middle cerebral artery occlusion in rats. Stroke. 2003;34: 2252-2257. (Pubitemid 37099845)
20. Menzies SA, Hoff JT, Betz AL. Middle cerebral artery occlusion in rats: a neurological and pathological evaluation of a reproducible model. Neurosurgery. 1992;31:100-116; discussion 106-7.
21. Shimony A, Zahger D, Gilutz H, et al. Cell free DNA detected by a novel method in acute ST-elevation myocardial infarction patients. Acute Card Care. 2010;12:109-111.
22. Joshi CN, Jain SK, Murthy PS. An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res Brain Res Protoc. 2004;13:11-17. (Pubitemid 38519594)
23. Xu XH, Zhang SM, Yan WM, et al. Development of cerebral infarction, apoptotic cell death and expression of X-chromosomelinked inhibitor of apoptosis protein following focal cerebral ischemia in rats. Life Sci. 2006;78:704-712.
24. Kaplan B, Brint S, Tanabe J, et al. Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke. 1991;22:1032-1039.
25. Zachariah RR, Schmid S, Buerki N, et al. Levels of circulating cellfree nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Obstet Gynecol. 2008;112:843-850.
26. Gormally E, Caboux E, Vineis P, et al. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res. 2007;635:105-117. (Pubitemid 46756399)
27. Zhong XY, Ladewig A, Schmid S, et al. Elevated level of cell-free plasma DNA is associated with breast cancer. Arch Gynecol Obstet. 2007;276:327-331. (Pubitemid 47397546)
28. Kamat AA, Baldwin M, Urbauer D, et al. Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker. Cancer. 116:1918-1925.
29. Grill S, Rusterholz C, Zanetti-Dallenbach R, et al. Potential markers of preeclampsia-a review. Reprod Biol Endocrinol. 2009;7:70.
30. Farina A, LeShane ES, Romero R, et al. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol. 2005;193:421-425. (Pubitemid 41159536)
31. Saukkonen K, Lakkisto P, Varpula M, et al. Association of cellfree plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med. 2007;33: 1624-1627. (Pubitemid 47312467)
32. Rhodes A, Wort SJ, Thomas H, et al. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care. 2006;10:R60.
33. Saukkonen K, Lakkisto P, Pettila V, et al. Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem. 2008;54:1000-1007. (Pubitemid 351793406)
34. Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999;79:1431-1568. (Pubitemid 29473320)
35. Toung TJ, Hurn PD, Traystman RJ, et al. Global brain water increases after experimental focal cerebral ischemia: effect of hypertonic saline. Crit Care Med. 2002;30:644-649. (Pubitemid 34214631)
36. Spranger M, Krempien S, Schwab S, et al. Excess glutamate in the cerebrospinal fluid in bacterial meningitis. J Neurol Sci. 1996;143: 126-131. (Pubitemid 26402798)
37. Bouley J, Fisher M, Henninger N. Comparison between coated vs. uncoated suture middle cerebral artery occlusion in the rat as assessed by perfusion/diffusion weighted imaging. Neurosci Lett. 2007;412:185-190. (Pubitemid 46109147)
38. Fox G, Gallacher D, Shevde S, et al. Anatomic variation of the middle cerebral artery in the Sprague-Dawley rat. Stroke. 1993; 24:2087-292; discussion 2092-3.
39. Ning ZY, Zhao DM, Liu HX, et al. Altered expression of the prion gene in rat astrocyte and neuron cultures treated with prion peptide 106-126. Cell Mol Neurobiol. 2005;25:1171-1183.
40. Niiro M, Simon RP, Kadota K, et al. Proximal branching patterns of middle cerebral artery (MCA) in rats and their influence on the infarct size produced by MCA occlusion. J Neurosci Methods. 1996;64:19-23. (Pubitemid 26069887)
41. Rodriguez-Yanez M, Castellanos M, Blanco M, et al. Vascular protection in brain ischemia. Cerebrovasc Dis. 2006;21:21-29.
42. Latour LL, Kang DW, Ezzeddine MA, et al. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004;56:468-477. (Pubitemid 39319336)
43. Pluta R, Lossinsky AS, Wisniewski HM, et al. Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest. Brain Res. 1994;633:41-52. (Pubitemid 24021242)
44. Belayev L, Busto R, Zhao W, et al. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 1996;739:88-96. (Pubitemid 26387366)